10-86681731-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The ENST00000361373.9(LDB3):c.617C>T(p.Thr206Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00000311 in 1,609,144 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T206A) has been classified as Likely benign.
Frequency
Consequence
ENST00000361373.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LDB3 | NM_007078.3 | c.617C>T | p.Thr206Ile | missense_variant | 5/14 | ENST00000361373.9 | NP_009009.1 | |
LDB3 | NM_001368067.1 | c.321+1574C>T | intron_variant | ENST00000263066.11 | NP_001354996.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LDB3 | ENST00000361373.9 | c.617C>T | p.Thr206Ile | missense_variant | 5/14 | 1 | NM_007078.3 | ENSP00000355296 | P4 | |
LDB3 | ENST00000263066.11 | c.321+1574C>T | intron_variant | 1 | NM_001368067.1 | ENSP00000263066 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152220Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248358Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134358
GnomAD4 exome AF: 0.00000275 AC: 4AN: 1456924Hom.: 0 Cov.: 32 AF XY: 0.00000414 AC XY: 3AN XY: 724092
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152220Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74358
ClinVar
Submissions by phenotype
Dilated cardiomyopathy 1C Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 03, 2003 | - - |
Myofibrillar myopathy 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 30, 2023 | The LDB3 gene has multiple clinically relevant transcripts. This variant occurs in alternate transcript NM_007078.3, and corresponds to NM_001080116.1:c.321+1574C>T in the primary transcript. This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 206 of the LDB3 protein (p.Thr206Ile). This variant is present in population databases (rs121908337, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of LDB3-related conditions and/or dilated cardiomyopathy (PMID: 14662268; Invitae). This variant is also known as T213I. ClinVar contains an entry for this variant (Variation ID: 4732). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this missense change affects LDB3 function (PMID: 19377068). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 16, 2019 | The p.T206I variant (also known as c.617C>T), located in coding exon 4 of the LDB3 gene, results from a C to T substitution at nucleotide position 617. The threonine at codon 206 is replaced by isoleucine, an amino acid with similar properties. In one study, this variant (also referred to as p.T213I, c.638C>T) was detected in a pediatric proband reported to have dilated cardiomyopathy (DCM), noncompaction, and conduction disease that improved on follow up to mild DCM. The parents were reportedly unaffected and did not have the variant. It is unclear if other genes associated with cardiomyopathy were analyzed in the proband (Vatta M et al. J. Am. Coll. Cardiol., 2003 Dec;42:2014-27). Functional studies suggest this variant may have some impact on protein function, but the clinical relevance is unclear (Arimura T et al. Cardiovasc. Res., 2009 Jul;83:80-8; Lin C et al. J. Biol. Chem., 2013 Oct;288:29403-13). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at